Tolvaptan for Advanced or Refractory Heart Failure
Status:
Terminated
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
This study will clarify the clinical usefulness of Tolvaptan therapy in patients with
complicated acute decompensated heart failure and hyponatremia (low blood sodium).